Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 670.01Cr 99Cr 86Cr 80Cr 74Cr 139.15Cr 9.47TCr 141.31Cr 946.03Cr 371.29Cr 4.71TCr 372.52Cr 364.33Cr 16TCr P/E 2026 *
12.5x
P/E 2027 * 10.5x
Enterprise Value 536.04Cr 79Cr 69Cr 64Cr 59Cr 111.33Cr 7.58TCr 113.05Cr 756.87Cr 297.05Cr 3.77TCr 298.03Cr 291.48Cr 13TCr EV / Sales 2026 *
0.3x
EV / Sales 2027 * 0.26x
Free-Float
51.88%
Yield 2026 *
4.06%
Yield 2027 * 4.57%
1 day-0.09%
1 week+6.58%
1 month+15.89%
3 months-7.97%
6 months-17.00%
Current year-9.25%
1 week 10.83
Extreme 10.83
11.8
1 month 9.9
Extreme 9.9
11.8
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
15.66
3 years 9.41
Extreme 9.41
26.96
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 22/11/2023
President 60 25/11/2019
Director of Finance/CFO 44 22/11/2023
Director TitleAgeSince
Chairman 60 01/06/2009
Chairman 61 01/06/2009
Director/Board Member 44 16/11/2016
Date Insider Type Main position Quantity % Market Cap.
11/05/26 Buy

Founder

43,71,400 1.0926%
18/12/25 Buy

Founder

15,50,700 0.3876%
17/12/25 Buy

Founder

20,04,500 0.5010%
Change 5-day change 1-year change 3-year change Capi.($)
-0.09%+6.58%-22.87%-53.71% 99Cr
+0.31%+6.49%-19.18%-30.63% 1.6TCr
+1.70%+7.49%-25.52%-35.66% 740.06Cr
-3.92%+3.09%-19.36%-9.54% 625.54Cr
+0.13%+4.36%-6.11%-29.19% 407.97Cr
+0.05%+4.28%-23.22%-45.99% 329.02Cr
-1.46%+2.45%+8.21%-32.44% 317.81Cr
+1.37%+3.90%-41.35%-22.79% 311.7Cr
-0.51%+2.07%-10.53%+7.46% 270.01Cr
-4.05%-2.27%+94.44% - 250.31Cr
Average -0.62%+2.95%-6.55%-28.05% 495.42Cr
Weighted average by Cap. -0.35%+4.35%-12.84%-27.47%

Financials

2026 *2027 *
Net sales 1.8TCr 267.18Cr 232.26Cr 216.18Cr 198.48Cr 374.82Cr 26TCr 380.62Cr 2.55TCr 1TCr 13TCr 1TCr 981.38Cr 43TCr 1.92TCr 283.63Cr 246.56Cr 229.49Cr 210.7Cr 397.89Cr 27TCr 404.06Cr 2.71TCr 1.06TCr 13TCr 1.07TCr 1.04TCr 45TCr
Net income 55Cr 8.07Cr 7.02Cr 6.53Cr 6Cr 11Cr 770.37Cr 11Cr 77Cr 30Cr 383.52Cr 30Cr 30Cr 1.29TCr 65Cr 9.62Cr 8.36Cr 7.78Cr 7.14Cr 13Cr 918.11Cr 14Cr 92Cr 36Cr 457.08Cr 36Cr 35Cr 1.53TCr
Net Debt -133.97Cr -20Cr -17Cr -16Cr -15Cr -28Cr -1.89TCr -28Cr -189.16Cr -74Cr -942.57Cr -74Cr -73Cr -3.16TCr -163.03Cr -24Cr -21Cr -20Cr -18Cr -34Cr -2.3TCr -34Cr -230.2Cr -90Cr -1.15TCr -91Cr -89Cr -3.85TCr
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
31/26/31 CN¥11.67 -0.09% 93,31,151
30/26/30 CN¥11.68 +0.78% 97,86,552
29/26/29 CN¥11.59 +2.02% 96,52,539
28/26/28 CN¥11.36 +0.26% 75,99,300
27/26/27 CN¥11.33 +3.47% 1,59,36,676
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
11.67CNY
Average target price
14.86CNY
Spread / Average Target
+27.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002727 Stock